Curable. Inc. (XKON:086460)
South Korea flag South Korea · Delayed Price · Currency is KRW
29,080
+3,480 (13.59%)
At close: Mar 12, 2025

Curable. Company Description

Curable. Inc. provides single nucleotide polymorphism (SNP) research and analysis services in South Korea. The company offers various services, such as genome analyzer; and sequencing and re-sequencing, immunoprecipitate sequencing, small RNA discovery and analysis, and digital gene expression profiling services.

It also provides SNP genotyping services; SNP discovery services; and microsatellites typing, DNA sequencing, bio-informatics, gene identification, and statistical analysis services.

The company serves pharmaceutical companies. The company was formerly known as SNP Genetics Inc. Curable.

Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Curable. Inc.
CountrySouth Korea
Founded2000
IndustryCommercial Physical and Biological Research
Employees16
CEOHyoung-Doo Shin

Contact Details

Address:
93 Dongtan-daero 23-gil
Hwaseong-si
South Korea
Phone82 31 376 1671
Websitecurablent.com

Stock Details

Ticker Symbol086460
ExchangeKorea New Exchange
Stock TypeCommon Stock
Reporting CurrencyKRW
SIC Code8731

Key Executives

NamePosition
Hyoung-Doo ShinChief Executive Officer